On May 30, 2024 Servier, a leader in oncology committed to delivering transformative therapies to patients, reported that it will underwrite a panel hosted by The Atlantic titled: "Bridging the Gap in Cancer Care for Adolescents and Young Adults" (AYA) (Press release, Servier, MAY 30, 2024, View Source [SID1234643886]). The event, which will also include an art exhibit showcasing the challenges and triumphs of the AYA cancer patient population, will take place in Chicago, concurrently with the 2024 American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) Annual Meeting.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"At Servier, our mission is to support patients far beyond delivering transformative new medicines," said David K. Lee, CEO of Servier Pharmaceuticals. "As a private Foundation, we are uniquely positioned to commit to prioritizing the long-term welfare of the patients we serve. Part of our commitment to patient-centric innovation involves fostering critical conversations about the experiences and needs of patients who are navigating life during and after a cancer diagnosis. We believe that continued dialogue on this important topic will drive advancements in care and improve outcomes for AYA patients in the future."
According to the National Cancer Institute, an estimated 84,100 AYAs between the ages of 15 to 39 will be diagnosed with cancer in the United States in 2024. This accounts for about 4.2% of all cancer diagnoses.1
These people also experience challenges distinct from those of pediatric and adult patients, and despite increased focus on survival and quality of life for AYA cancer patients, gaps in knowledge remain.
"Being governed by a private Foundation allows us to prioritize the needs of patients and take a long-term approach to our global impact on healthcare," said Arnaud Lallouette, Executive Vice President, Global Medical and Patient Affairs at Servier. "At Servier, we are inspired by the resilience of our patients and are honored to work hand in hand with them to not just address medical needs, but to build a more equitable healthcare system that addresses their comprehensive needs."
This dedication is evident in our patient-first philosophy, which guides every aspect of our operations. From pioneering research and development to meaningful community engagement, Servier is steadfast in its mission to improve the lives of cancer patients worldwide.
The event will be held on Friday, May 31 at 6:30 PM CT at the Lacuna Lofts in Chicago, IL. For more information and to register, visit: View Source
*PatientView’s 2023-2024 Corporate Reputation of Pharma
1 "Adolescents and Young Adults (Ayas) with Cancer." National Institute of Health, April 26, 2024. View Source